vs

Legacy Housing Corp(LEGH)与ROCKWELL MEDICAL, INC.(RMTI)财务数据对比。点击上方公司名可切换其他公司

Legacy Housing Corp的季度营收约是ROCKWELL MEDICAL, INC.的1.4倍($25.5M vs $18.3M),Legacy Housing Corp净利率更高(32.2% vs -3.0%,领先35.2%),ROCKWELL MEDICAL, INC.同比增速更快(-25.6% vs -30.6%),Legacy Housing Corp自由现金流更多($15.7M vs $2.2M),过去两年Legacy Housing Corp的营收复合增速更高(-9.1% vs -10.1%)

Legacy Housing Corp是美国知名的经济型预制住宅、微型住宅及配套居住单元制造商,主要面向北美中低收入消费群体,提供可定制住房解决方案、配套建材及相关售后服务,服务个人及社区开发类客户。

罗克韦尔医疗成立于1996年,总部位于美国密歇根州威克瑟姆,是一家上市制药企业,核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。

LEGH vs RMTI — 直观对比

营收规模更大
LEGH
LEGH
是对方的1.4倍
LEGH
$25.5M
$18.3M
RMTI
营收增速更快
RMTI
RMTI
高出5.0%
RMTI
-25.6%
-30.6%
LEGH
净利率更高
LEGH
LEGH
高出35.2%
LEGH
32.2%
-3.0%
RMTI
自由现金流更多
LEGH
LEGH
多$13.5M
LEGH
$15.7M
$2.2M
RMTI
两年增速更快
LEGH
LEGH
近两年复合增速
LEGH
-9.1%
-10.1%
RMTI

损益表 — Q4 FY2025 vs Q4 FY2025

指标
LEGH
LEGH
RMTI
RMTI
营收
$25.5M
$18.3M
净利润
$8.2M
$-554.0K
毛利率
26.4%
21.1%
营业利润率
40.4%
-2.2%
净利率
32.2%
-3.0%
营收同比
-30.6%
-25.6%
净利润同比
-43.5%
26.7%
每股收益(稀释后)
$0.38
$-0.01

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
LEGH
LEGH
RMTI
RMTI
Q4 25
$25.5M
$18.3M
Q3 25
$28.8M
$15.9M
Q2 25
$38.4M
$16.1M
Q1 25
$24.3M
$18.9M
Q4 24
$36.7M
$24.7M
Q3 24
$30.2M
$28.3M
Q2 24
$31.7M
$25.8M
Q1 24
$30.8M
$22.7M
净利润
LEGH
LEGH
RMTI
RMTI
Q4 25
$8.2M
$-554.0K
Q3 25
$8.6M
$-1.8M
Q2 25
$14.7M
$-1.5M
Q1 25
$10.3M
$-1.5M
Q4 24
$14.5M
$-756.0K
Q3 24
$15.8M
$1.7M
Q2 24
$16.2M
$343.0K
Q1 24
$15.1M
$-1.7M
毛利率
LEGH
LEGH
RMTI
RMTI
Q4 25
26.4%
21.1%
Q3 25
20.2%
14.3%
Q2 25
32.4%
15.6%
Q1 25
29.2%
16.1%
Q4 24
27.3%
14.7%
Q3 24
29.2%
22.0%
Q2 24
31.9%
17.6%
Q1 24
33.6%
13.5%
营业利润率
LEGH
LEGH
RMTI
RMTI
Q4 25
40.4%
-2.2%
Q3 25
33.7%
-9.9%
Q2 25
43.8%
-8.4%
Q1 25
47.7%
-7.2%
Q4 24
42.3%
-2.1%
Q3 24
50.8%
6.8%
Q2 24
50.6%
2.0%
Q1 24
54.3%
-5.8%
净利率
LEGH
LEGH
RMTI
RMTI
Q4 25
32.2%
-3.0%
Q3 25
30.0%
-11.0%
Q2 25
38.3%
-9.3%
Q1 25
42.3%
-8.0%
Q4 24
39.5%
-3.1%
Q3 24
52.4%
5.9%
Q2 24
51.1%
1.3%
Q1 24
49.1%
-7.6%
每股收益(稀释后)
LEGH
LEGH
RMTI
RMTI
Q4 25
$0.38
$-0.01
Q3 25
$0.35
$-0.05
Q2 25
$0.60
$-0.05
Q1 25
$0.41
$-0.04
Q4 24
$0.59
$-0.02
Q3 24
$0.64
$0.04
Q2 24
$0.65
$0.01
Q1 24
$0.60
$-0.06

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
LEGH
LEGH
RMTI
RMTI
现金及短期投资手头流动性
$8.5M
$10.7M
总债务越低越好
股东权益账面价值
$528.6M
$37.0M
总资产
$580.3M
$57.1M
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
LEGH
LEGH
RMTI
RMTI
Q4 25
$8.5M
$10.7M
Q3 25
$13.6M
$13.6M
Q2 25
$2.6M
$12.5M
Q1 25
$3.4M
$11.4M
Q4 24
$1.1M
$15.7M
Q3 24
$570.0K
$12.3M
Q2 24
$60.0K
$11.9M
Q1 24
$621.0K
$6.6M
股东权益
LEGH
LEGH
RMTI
RMTI
Q4 25
$528.6M
$37.0M
Q3 25
$521.6M
$37.0M
Q2 25
$512.8M
$30.4M
Q1 25
$503.7M
$31.5M
Q4 24
$494.0M
$32.6M
Q3 24
$479.3M
$29.1M
Q2 24
$463.2M
$23.5M
Q1 24
$450.4M
$20.6M
总资产
LEGH
LEGH
RMTI
RMTI
Q4 25
$580.3M
$57.1M
Q3 25
$557.9M
$57.5M
Q2 25
$552.0M
$52.6M
Q1 25
$544.6M
$54.0M
Q4 24
$534.2M
$59.2M
Q3 24
$521.4M
$57.1M
Q2 24
$514.9M
$53.0M
Q1 24
$510.0M
$50.7M

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
LEGH
LEGH
RMTI
RMTI
经营现金流最新季度
$19.0M
$2.3M
自由现金流经营现金流 - 资本支出
$15.7M
$2.2M
自由现金流率自由现金流/营收
61.6%
12.0%
资本支出强度资本支出/营收
13.1%
0.5%
现金转化率经营现金流/净利润
2.32×
过去12个月自由现金流最近4个季度
$28.2M
$-1.2M

8季度趋势,按日历期对齐

经营现金流
LEGH
LEGH
RMTI
RMTI
Q4 25
$19.0M
$2.3M
Q3 25
$7.2M
$-1.3M
Q2 25
$6.1M
$1.8M
Q1 25
$4.9M
$-3.5M
Q4 24
$7.9M
$865.0K
Q3 24
$13.8M
$4.3M
Q2 24
$3.5M
$1.4M
Q1 24
$10.8M
$-2.4M
自由现金流
LEGH
LEGH
RMTI
RMTI
Q4 25
$15.7M
$2.2M
Q3 25
$5.1M
$-1.5M
Q2 25
$3.7M
$1.7M
Q1 25
$3.6M
$-3.5M
Q4 24
$6.0M
$470.0K
Q3 24
$9.1M
$4.1M
Q2 24
$1.7M
$1.2M
Q1 24
$9.9M
$-2.5M
自由现金流率
LEGH
LEGH
RMTI
RMTI
Q4 25
61.6%
12.0%
Q3 25
17.8%
-9.6%
Q2 25
9.6%
10.5%
Q1 25
15.0%
-18.8%
Q4 24
16.4%
1.9%
Q3 24
30.2%
14.4%
Q2 24
5.4%
4.5%
Q1 24
32.2%
-11.1%
资本支出强度
LEGH
LEGH
RMTI
RMTI
Q4 25
13.1%
0.5%
Q3 25
7.1%
1.4%
Q2 25
6.2%
1.0%
Q1 25
5.2%
0.3%
Q4 24
5.1%
1.6%
Q3 24
15.6%
0.7%
Q2 24
5.5%
1.1%
Q1 24
2.8%
0.6%
现金转化率
LEGH
LEGH
RMTI
RMTI
Q4 25
2.32×
Q3 25
0.83×
Q2 25
0.41×
Q1 25
0.48×
Q4 24
0.54×
Q3 24
0.88×
2.57×
Q2 24
0.21×
4.20×
Q1 24
0.71×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

LEGH
LEGH

Commercial Sales$8.6M34%
Retail Store Sales$6.0M24%
Inventory Finance Sales$5.0M20%
Direct Sales$4.4M17%
Other$1.5M6%

RMTI
RMTI

US$15.9M87%
Non Us$2.4M13%

相关对比